These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4353172)

  • 41. Cardiac actions of glucagon.
    Lucchesi BR
    Circ Res; 1968 Jun; 22(6):777-87. PubMed ID: 4385510
    [No Abstract]   [Full Text] [Related]  

  • 42. Endothelin ETA-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium.
    Vogelsang M; Broede-Sitz A; Schäfer E; Zerkowski HR; Brodde OE
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):344-7. PubMed ID: 7511768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator.
    Fuller RW; Snoddy HD; Bromer WW
    Mol Pharmacol; 1972 May; 8(3):345-52. PubMed ID: 4339289
    [No Abstract]   [Full Text] [Related]  

  • 44. Frequency modulation of the inotropic action of isoproterenol in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):314-25. PubMed ID: 6262482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased responsiveness of the adenylate cyclase system on left atria from hypothyroid rats.
    Brodde OE; Schümann HJ; Wagner J
    Mol Pharmacol; 1980 Mar; 17(2):180-6. PubMed ID: 6248755
    [No Abstract]   [Full Text] [Related]  

  • 46. Alkaline phosphatase. Possible induction by cyclic AMP after cholera enterotoxin administration.
    Baker A; Kaplan M; Kimberg DV
    J Clin Invest; 1973 Nov; 52(11):2928-34. PubMed ID: 4356003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of myocardial cyclic AMP by isoproterenol, glucagon and acetylcholine.
    Lee TP; Kuo JF; Greengard P
    Biochem Biophys Res Commun; 1971 Nov; 45(4):991-7. PubMed ID: 4330147
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of relative levels of cyclic AMP in tissues or cells prelabeled with radioactive adenine.
    Kebabian JW; Kuo JF; Greengard P
    Adv Cyclic Nucleotide Res; 1972; 2():131-7. PubMed ID: 4352293
    [No Abstract]   [Full Text] [Related]  

  • 49. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M; Yamashita S; Taira N
    J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholecystokinetic effect and concentration of cyclic AMP in gall-bladder muscle in vitro.
    Andersson KE; Andersson R; Hedner P
    Acta Physiol Scand; 1972 Aug; 85(4):511-6. PubMed ID: 4342266
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase.
    Newton NE; Hornbrook KR
    J Pharmacol Exp Ther; 1972 Jun; 181(3):479-88. PubMed ID: 5033014
    [No Abstract]   [Full Text] [Related]  

  • 53. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of the increased cardiac Ca2+ uptake induced by isoprenaline in DOCA-salt pretreated rats.
    Günther T; Vormann J; Förster R
    Arzneimittelforschung; 1984; 34(1):26-9. PubMed ID: 6322811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of the adenosine 3',5'-monophosphate-adenyl cyclase system in the livers of developing rats.
    Butcher FR; Potter VR
    Cancer Res; 1972 Oct; 32(10):2141-7. PubMed ID: 4404163
    [No Abstract]   [Full Text] [Related]  

  • 56. Control of cardiac-muscle contraction.
    N Engl J Med; 1968 Jul; 279(1):43-4. PubMed ID: 4297980
    [No Abstract]   [Full Text] [Related]  

  • 57. [Glucagon--a therapeutic alternative in heart failure?].
    Andersen HT
    Nord Med; 1971 Nov; 86(47):1369-75. PubMed ID: 4333034
    [No Abstract]   [Full Text] [Related]  

  • 58. Isoproterenol and glucagon effects in perfused hearts from spontaneously hypertensive and normotensive rats.
    Largis EE; Allen DO; Clark J; Ashmore J
    Biochem Pharmacol; 1973 Jul; 22(14):1735-44. PubMed ID: 4351901
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanism of action of epinephrine and glucagon on the canine heart. Evidence for increase in sarcotubular calcium stores mediated by cyclic 3',5'-AMP.
    Entman ML; Levey GS; Epstein SE
    Circ Res; 1969 Oct; 25(4):429-38. PubMed ID: 4310439
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence that cyclic AMP is not involved in the chronotropic action of glucagon in the adult mouse heart.
    Clark CM
    Endocrinology; 1976 Jul; 99(1):23-9. PubMed ID: 181238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.